AU2001245961A1 - Dna-cleaving antitumor agents - Google Patents
Dna-cleaving antitumor agentsInfo
- Publication number
- AU2001245961A1 AU2001245961A1 AU2001245961A AU4596101A AU2001245961A1 AU 2001245961 A1 AU2001245961 A1 AU 2001245961A1 AU 2001245961 A AU2001245961 A AU 2001245961A AU 4596101 A AU4596101 A AU 4596101A AU 2001245961 A1 AU2001245961 A1 AU 2001245961A1
- Authority
- AU
- Australia
- Prior art keywords
- cleaving
- dna
- antitumor agents
- antitumor
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/533,723 US6297284B1 (en) | 1998-07-16 | 2000-03-23 | DNA-cleaving antitumor agents |
US09533723 | 2000-03-23 | ||
PCT/US2001/009334 WO2001070217A1 (en) | 2000-03-23 | 2001-03-22 | Dna-cleaving antitumor agents |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001245961A1 true AU2001245961A1 (en) | 2001-10-03 |
Family
ID=24127186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001245961A Abandoned AU2001245961A1 (en) | 2000-03-23 | 2001-03-22 | Dna-cleaving antitumor agents |
Country Status (4)
Country | Link |
---|---|
US (1) | US6297284B1 (zh) |
AU (1) | AU2001245961A1 (zh) |
TW (1) | TWI246422B (zh) |
WO (1) | WO2001070217A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6686345B2 (en) * | 1998-07-16 | 2004-02-03 | Research Development Foundation | DNA-cleaving antitumor agents |
US6908948B1 (en) * | 1998-07-16 | 2005-06-21 | Research Development Foundation | DNA-cleaving antitumor agents |
US7105491B2 (en) * | 1999-01-06 | 2006-09-12 | Wisconsin Alumni Research Foundation (Warf) | Biosynthesis of enediyne compounds by manipulation of C-1027 gene pathway |
US11320428B2 (en) * | 2017-04-20 | 2022-05-03 | The Hong Kong University Of Science And Technology | Probe for dual-mode bio-imaging |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5767142A (en) * | 1996-03-20 | 1998-06-16 | Rutgers, The State University Of New Jersey | Trisbenzimidazoles useful as topoisomerase I inhibitors |
-
2000
- 2000-03-23 US US09/533,723 patent/US6297284B1/en not_active Expired - Fee Related
-
2001
- 2001-03-22 AU AU2001245961A patent/AU2001245961A1/en not_active Abandoned
- 2001-03-22 WO PCT/US2001/009334 patent/WO2001070217A1/en active Application Filing
- 2001-04-12 TW TW090108813A patent/TWI246422B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2001070217A1 (en) | 2001-09-27 |
TWI246422B (en) | 2006-01-01 |
US6297284B1 (en) | 2001-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002224595A1 (en) | Antitumor agents | |
AU2002221344A1 (en) | Antiviral agents | |
AU2001228708A1 (en) | Coin-validation arrangement | |
AU2002210714A1 (en) | Substituted quinolines as antitumor agents | |
AU2001252135A1 (en) | Therapeutic agents | |
AUPQ105499A0 (en) | Antiviral agents | |
AU2001288040A1 (en) | Homeostasis-maintaining agents | |
AU2882801A (en) | Azepine derivatives | |
AU2002214284A1 (en) | Anti-helicobacterial agents | |
AU5983900A (en) | Combined preparations comprising antitumor agents | |
AUPQ288499A0 (en) | Antiviral agents | |
AU2001294969A1 (en) | Platinum complexes as antitumor agents | |
AU4548899A (en) | Naphtho- and dihydrobenzo-thiophene derivatives as cytotoxic antitumor agents | |
AU2001289635A1 (en) | Polymeric conjugates of antitumor agents | |
EP1109552A4 (en) | NOVEL ANTICANCING AGENTS GENERATING DNA CLEAVAGE | |
AU7446000A (en) | Antitumor agents | |
AU2001273903A1 (en) | Therapeutic agents | |
AU2001262263A1 (en) | Line arrangement | |
AU2001232332A1 (en) | Leptin-resistance ameliorating agents | |
AU2001240024A1 (en) | Camptothecin complexes | |
AU2001245961A1 (en) | Dna-cleaving antitumor agents | |
AU2001280465A1 (en) | Autocycle | |
AU2001274683A1 (en) | Contrast agents | |
AU2001260045A1 (en) | Secure pants | |
AU2001281142A1 (en) | Diazepinones as antiviral agents |